On April 23, 2026, the DOJ and DEA announced an action that the cannabis industry has been waiting years for. It’s also being misread across every headline and group chat I’ve seen since.
Here’s what actually happened, what didn’t, and how operators should be thinking about 280E over the next 90 days.
What the Order Does
The DOJ immediately placed two specific categories of marijuana into Schedule III of the Controlled Substances Act:
- FDA-approved drug products containing marijuana
- Marijuana products regulated by a qualifying state-issued medical marijuana license
That’s the full scope. Acting Attorney General Todd Blanche took this step under his authority to carry out U.S. obligations under the Single Convention on Narcotic Drugs, following President Trump’s December 18, 2025 Executive Order on medical marijuana and CBD research.
What the Order Does Not Do
The order does not reschedule marijuana broadly. Adult-use marijuana stays in Schedule I. Hemp remains separately regulated. And it doesn’t, by itself, resolve how the IRS will treat the reclassified products for 280E purposes.
The broader Schedule I to Schedule III rescheduling is still working through a separate track. DEA withdrew the prior administration’s notice of hearing and is restarting the administrative process, which now begins June 29, 2026. A new notice of hearing is being published in the Federal Register.
This is a partial, targeted reclassification wrapped in language that sounds industry-wide. The distinction matters.
Why 280E Is the Real Story
IRC §280E disallows ordinary business deductions for any business trafficking in controlled substances listed in Schedule I or II. Schedule III isn’t covered.
That’s why this order matters, and why it matters only for the products it actually covers.
The Three Categories of Operators
Every cannabis operator now sits in one of three buckets. Your bucket determines what changes for you.
1. Medical-Only Operators in Qualifying States
If your business operates exclusively under a qualifying state medical license, the products you handle arguably now sit outside the scope of 280E.
This is the category with the most potential upside, and the most open questions:
- How the IRS will interpret the effective date
- Whether amended returns for prior years are available or advisable
- How “qualifying state-issued license” will be defined in enforcement practice
- How state-level 280E conformity (or non-conformity) interacts with the change
Do not assume automatic relief. Do not file an amended return based on a press release. Talk to your tax advisor first.
2. Dual-License Operators (Medical + Adult-Use)
If you hold both medical and adult-use licenses, the order creates a revenue segmentation necessity you didn’t have yesterday.
Your medical revenue may warrant different 280E treatment than your adult-use revenue. That means:
- COGS allocations between license types now carry tax weight, not just operational weight
- Entity structure becomes a tax planning variable
- Shared services, facilities, and inventory need defensible allocation methodologies
- Your accounting system may need to be re-tooled to support the segmentation
This is the category where good accounting becomes the difference between capturing the benefit and leaving it on the table.
3. Adult-Use-Only Operators
If your business is exclusively adult-use, nothing has changed for you yet. 280E still applies in full.
Your date to watch is June 29, 2026. Until that hearing concludes and the broader rescheduling takes effect, keep your 280E compliance tight and your cost accounting defensible.
What to Do This Week
The next 30 to 90 days are a planning window, not a wait-and-see window.
Map your licenses. Inventory every license you hold, the state that issued it, and whether it qualifies as medical, adult-use, or both.
Segment your revenue. Pull a trailing 12-month revenue breakdown by license type. If your accounting system can’t produce this cleanly, that’s the first thing to fix.
Review your cost allocations. Any shared cost needs a methodology that holds up under IRS scrutiny if medical and adult-use end up taxed differently.
Don’t file amended returns yet. The interaction between the DOJ order, IRS guidance, and 280E’s statutory text isn’t settled. Moving too fast creates exposure, not savings.
Watch June 29. Scenario-plan for both a full Schedule III outcome and a delayed one.
The Bottom Line
For medical operators in qualifying states, this may be the most significant federal tax development cannabis has seen. For dual-license operators, it creates a new planning dimension. For adult-use operators, it’s a signal of direction, not a change in your current position.
The operators who capture the most value from this moment will be the ones who understand exactly what changed, exactly what didn’t, and exactly where their business sits. The ones who assume “280E is dead” and act accordingly are going to create problems for themselves.
If you want a clear read on what this order means for your business, that’s the conversation we’re having with clients this week. Reach out.
Melissa Diaz, CPA, is a Partner and Chief Revenue Officer at High Rock Accounting, where she leads the firm’s cannabis vertical. She is a 2026 Forbes Best-in-State CPA and a frequent speaker on cannabis tax, compliance, and industry strategy.
This article is for informational purposes only and does not constitute tax, legal, or accounting advice. Cannabis operators should consult with a qualified advisor before making decisions based on the matters discussed here.
👉 Connect with Melissa Diaz on LinkedIn
👉 Connect with High Rock on LinkedIn
Enjoyed this article? Consider Sharing
Author
